GENE ONLINE|News &
AI Tool Maps Cellular Drug Responses to Aid Disease Treatment Development
Researchers at the University of Virginia School of Medicine have developed a computational tool designed to enhance the process of creating new treatments for diseases. Unlike existing artificial intelligence (AI) methods, this tool provides insights into both the patient populations that may benefit from specific drugs and the mechanisms by which these drugs interact with cells.
The newly created AI system aims to address gaps in current drug development approaches by offering detailed predictions about cellular responses to medications. This capability allows scientists to better understand how treatments function at a molecular level, potentially streamlining efforts to identify effective therapies for various conditions. The researchers suggest that this dual focus—on patient suitability and cellular activity—could help refine treatment strategies and reduce the time required for drug development.
Date: 19 March, 2025
Newsflash | Powered by GeneOnline AI
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
CDC Awards $3 Million to Louisiana Breast and Cervical Health Program for Cancer Screenings
2026-08-12
JAMA Pediatrics Study Finds Hospital-Wide Documentation of Curbside Consultations Improves Patient Safety
2026-08-12
iNaturalist Photographs Help Researchers Double Known Number of Harvestman Species Exhibiting Parental Care
2026-08-12
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
